STOCK TITAN

VolitionRx Limited to Host Capital Markets Day on Friday May 13

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

VolitionRx Limited (NYSE AMERICAN: VNRX) will host a hybrid Capital Markets Day on May 13, 2022, at 10 a.m. Eastern Time. The event, held at Siebert Hall, NYSE, will feature the executive team providing strategic updates and discussing key growth drivers. Topics include veterinary market opportunities, clinical results, and financial metrics. Attendees can register for virtual participation. Presentations will be available on the company’s website, with a replay offered post-event.

Positive
  • None.
Negative
  • None.

AUSTIN, Texas, May 5, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company plans to host a Capital Markets Day in a hybrid format on  Friday, May 13, 2022, at 10 a.m. U.S. Eastern Time.  Volition's executive team will provide strategic updates and discuss the Company's key short-term growth drivers.

                Event: VolitionRx Limited Capital Markets Day
                Date: Friday, May 13, 2022
                Time: 10:00 a.m. Eastern time
                In-person Venue: Siebert Hall, New York Stock Exchange
                To attend in person, contact investorrelations@volition.com
                To attend virtually please register HERE

Company presentations will cover:

Nu.Q® Vet

  • Veterinary market opportunity (reference lab and point of care)
  • Heska licensing deal (up to $28 million in milestone payments PLUS ongoing revenue for tests sold)
  • Other licensing updates
  • New Product updates

Nu.Q® NETs

  • Clinical Results to-date
  • Clinical and Regulatory plan including FDA timings
  • Market opportunity

- Financial Update: Key Metrics and Considerations

A question-and-answer session with management will follow the prepared remarks and formal presentation.

To attend the event in-person please contact investorrelations@volition.com

To access the virtual event, register by clicking  HERE.

The event will be webcast and the presentations will be posted to Volition's website. A replay will be made available.

For additional information or questions please contact Investor Relations at investorrelation@volition.com or call 646 650 1351

Volition is developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including cancer in both humans and animals. For more information about Volition's Nu.Q® technology go to: www.volition.com

About Volition

Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Volition's research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.

For more information about Volition, visit Volition's website or connect with us via Twitter, LinkedIn, and Facebook.

Media Enquiries:

Louise Batchelor/Debra Daglish, Volition, mediarelations@volition.com +44 (0)7557 774620

Investor Enquiries:

Scott Powell, Volition, investorrelations@volition.com +1 (646) 650 1351

Cision View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-to-host-capital-markets-day-on-friday-may-13-301540753.html

SOURCE VolitionRx Limited

FAQ

What is the date and time of VolitionRx's Capital Markets Day?

VolitionRx's Capital Markets Day is on May 13, 2022, at 10 a.m. Eastern Time.

Where is VolitionRx's Capital Markets Day being held?

The event will take place at Siebert Hall, New York Stock Exchange.

How can I attend VolitionRx's Capital Markets Day virtually?

To attend virtually, you can register through the provided link on Volition's press release.

What topics will be covered at the VolitionRx Capital Markets Day?

Topics include Nu.Q Vet opportunities, clinical results of Nu.Q NETs, and key financial metrics.

Will presentations from VolitionRx's Capital Markets Day be available later?

Yes, the presentations will be posted on Volition's website, and a replay will be available.

VolitionRX Limited

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Stock Data

56.49M
70.00M
22.82%
19.11%
0.48%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
HENDERSON